Nov 1 (Reuters) – Johnson & Johnson: * J&J – REPORTS POSITIVE SURVIVAL AND OUTCOMES WITH IMPELLA IN HRPCI * J&J – REGISTRY DATA SHOW LOWER MORTALITY WITH IMPELLA IN HRPCI THAN CHIP-BCIS3 Source text:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 1 (OPTA) - Results from the WTA 250, Chennai Open Women's Singles matches on…
VIDEO SHOWS: PLAYERS AND OFFICIALS PAYING TRIBUTE TO THE VICTIMS OF THE SPAIN TRAIN CRASH…
Nov 1 (Reuters) - Russia's FSB security service said on Sunday that an underage Russian…
By Ruma Paul DHAKA, Nov 1 (Reuters) - Bangladesh said on Sunday it had set…
By Lewis Krauskopf NEW YORK, Oct 30 (Reuters) - US midterm elections, a heavy slate…
* Bangladesh forms wage board to address demands for higher pay * Garment protests force…